Primate testing of TGN1412: Right target, wrong cell

British Journal of Pharmacology

Volumn 161, Issue 3, 2010, Pages 509-511

  Pallardy, M ^a   Hunig T ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

CD28; cytokine release syndrome; PBMC assays; preclinical safety testing; primate studies; TGN1412

Indexed keywords

CD28 ANTIGEN; MONOCLONAL ANTIBODY; TGN1412; UNCLASSIFIED DRUG;

CYTOKINE RELEASE; DRUG BINDING; DRUG INHIBITION; DRUG MECHANISM; DRUG TARGETING; HUMAN; IN VITRO STUDY; NONHUMAN; NOTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; CLINICAL TRIALS, PHASE I AS TOPIC; CYTOKINES; DRUG EVALUATION, PRECLINICAL; HUMANS; IMMUNOLOGIC MEMORY; MACACA FASCICULARIS; T-LYMPHOCYTES; TOXICITY TESTS;

EID: 77956302693     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00925.x     Document Type: Note

References (9)

1. Duff GW (2006). Expert Scientific Group on Phase One Clinical Trials Final Report. Stationery Office : Norwich, UK.
2. + effector memory T-cells. Br J Pharmacol 161 : 512 526.
3. EMA, European Medicines Agency (2007). Guideline on strategies to identify and mitigate risks for first-in human clinical trials with investigational medicinal products.
4. Gogishvili T, Langenhorst D, Luhder F, Elias F, Elflein K, Dennehy KM et al. (2009). Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice. Plos ONE 4 : e4643.
5. Hanke T (2006). Lessons from TGN1412. Lancet 368 : 1569-1570. author reply 1570.
6. Hunig T (2007). Manipulation of regulatory T-Cell number and function with CD28-specific monoclonal antibodies. Adv Immunol 95 : 111 148.
7. Kenter MJ, Cohen AF (2006). Establishing risk of human experimentation with drugs: lessons from TGN1412. Lancet 368 : 1387 1391.
8. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC et al. (2002). Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168 : 29 43.
9. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD et al. (2006). Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355 : 1018 1028.